Role of Monocytes in the Pathogenesis of Dengue

Adikari TN, Gomes L, Wickramasinghe N et al (2016) Dengue NS1 antigen contributes to disease severity by inducing interleukin (IL)-10 by monocytes. Clin Exp Immunol 184:90–100 Amorim JH, Alves RP dos Boscardin S SB et al (2014) The dengue virus non-structural 1 protein: Risks and benefits. Virus Res 181:53–60 Ancuta P, Rao R, Moses A et al (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 197:1701–1707 Anderson KB, Chunsuttiwat S, Nisalak A et al (2007) Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 369:1452–1459 Appanna R, Wang SM, Ponnampalavanar S et al (2012) Cytokine factors present in dengue patient sera induces alterations of junctional proteins in human endothelial cells. Am J Trop Med Hyg 87:936–942 Arias J, Valero N, Mosquera J et al (2014) Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue. Virology 452–453:42–51 Aye KS, Charngkaew K, Win N et al (2014) Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Hum Pathol 45:1221–1233 Azeredo EL, Neves-Souza PC, Alvarenga AR et al (2010) Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology 130:202–216 Balakrishnan T, Bela-Ong DB, Toh YX et al (2011) Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. PLoS One 6:e29430 Balsitis SJ, Coloma J, Castro G et al (2009) Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg 80:416–424 Balsitis SJ, Williams KL, Lachica R et al (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6:e1000790 Beatty PR, Puerta-Guardo H, Killingbeck SS et al (2015) Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med 7:304ra141 Beltrán D, López-Vergès S (2014) NK cells during dengue disease and their recognition of dengue virus-infected cells. Front Immunol 5:192 Bhatt S, Gething PW, Brady OJ et al (2013) The global distribution and burden of dengue. Nature 496:504–507 Bosch I, Xhaja K, Estevez L et al (2002) Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 76:5588–5597 Bozza FA, Cruz OG, Zagne SM et al (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8:86 Burbano C, Villar-Vesga J, Orejuela J et al (2018) Potential involvement of platelet-derived microparticles and microparticles forming immune complexes during monocyte activation in patients with systemic lupus erythematosus. Front Immunol 9:322 Burke-Gaffney A, Keenan AK (1993) Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 alpha/beta, tumor necrosis factor-alpha and interferon-gamma. Immunopharmacology 25:1–9 Chakravarti A, Kumaria R (2006) Circulating levels of tumour necrosis factor-α and interferon-γ in patients with dengue and dengue haemorrhagic fever during an outbreak. Indian J Med Res 123:25–30 Chareonsirisuthigul T, Kalayanarooj S, Ubol S (2007) Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 88(Pt 2):365–375 Chau TNB, Hieu NT, Anders KL et al (2009) Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants. J Infect Dis 200:1893–1900 Chen YC, Wang SY (2002) Activation of terminally differentiated human monocytes / macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol 76:9877–9887 Chen YC, Wang SY, King CC (1999) Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol 73:2650–2657 Chen J, Ng MM, Chu JJ (2015) Activation of TLR2 and TLR6 by dengue NS1 protein and its implications in the immunopathogenesis of dengue virus infection. PLoS Pathog 11:e1005053 Chousterman BG, Boissonnas A, Poupel L et al (2016) Ly6Chigh monocytes protect against kidney damage during sepsis via a CX3CR1-dependent adhesion mechanism. J Am Soc Nephrol 27:792–803 Clark KB, Noisakran S, Onlamoon N et al (2012) Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow. PLoS One 7:e52902 Collison JL, Carlin LM, Eichmann M et al (2015) Heterogeneity in the locomotory behavior of human monocyte subsets over human vascular endothelium in vitro. J Immunol 195:1162–1170 Cros J, Cagnard N, Woollard K et al (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33:375–386 Cruz-Oliveira C, Freire JM, Conceição TM et al (2015) Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol Rev 39:155–170 da Silva Voorham JM, Rodenhuis-Zybert IA, Ayala Nuñez NV et al (2012) Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2. PLoS One 7:e29957 Dalrymple NA, Mackow ER (2012) Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol 86:6408–6415 Dejnirattisai W, Jumnainsong A, Onsirisakul N et al (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745–748 Devignot S, Sapet C, Duong V et al (2010) Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue. PLoS One 5:e11671 Dewi BE, Takasaki T, Kurane I (2004) In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods 121:171–180 Diamond MS, Edgil D, Roberts TG et al (2000) Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 74:7814–7823 Duong V, Ly S, Try P et al (2011) Clinical and virological factors influencing the performance of a ns1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl Trop Dis 5:e1244 Durbin AP, Vargas MJ, Wanionek K et al (2008) Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 376:429–435 Espina LM, Valero NJ, Hernández JM et al (2003) Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg 68:48–53 Falconar AK (1997) The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 142:897–916 Garcia-Bates TM, Cordeiro MT, Nascimento EJ et al (2013) Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients. J Immunol 190:80–87 Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71–82 Goncalvez AP, Engle RE, St Claire MS et al (2007) Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci USA 104:9422–9427 Guzman M, Kouri G, Bravo J et al (2002) Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis 6:118–124 Halstead SB (1979) In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 140:527–533 Halstead SB (2007) Dengue. Lancet 370:1644–1652 Halstead SB (2008) Pathogenesis: risk factors prior to infection. In: Halstead SB (ed) Dengue. Imperial College Press, London, pp 219–256 Halstead SB, O’Rourke EJ (1977) Dengue viruses and mononuclear phagocytes. Infection enhancement by non-neutralizing antibody. J Exp Med 146:201–217 Halstead SB, Marchette N, Sung Chow J et al (1976) Dengue virus replication enhancement in peripheral blood leukocytes from immune human beings. Proc Soc Exp Biol Med 151:136–139 Halstead SB, O´Rourke EJ, Allison AC (1977) Dengue viruses and mononuclear phagocytes II: identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med 146:218–229 Halstead SB, Mahalingam S, Marovich MA et al (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10:712–722 Jessie K, Fong MY, Devi S et al (2004) Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189:1411–1418 Kanlaya R, Pattanakitsakul S, Sinchaikul S et al (2009) Alterations in actin cytoskeletal assembly and junctional protein complexes in human endothelial cells induced by dengue virus infection and mimicry of leukocyte transendothelial migration. J Proteome Res 8:2551–2562 Kelley JF, Kaufusi PH, Nerurkar VR (2012) Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability. Virology 422:326–337 Klomporn P, Panyasrivanit M, Wikan N et al (2011) Dengue infection of monocytic cells activates ER stress pathways, but apoptosis is induced through both extrinsic and intrinsic pathways. Virology 409:189–197 Kou Z, Quinn M, Chen H et al (2008) Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) Infection among human peripheral blood mononuclear cells. J Med Virol 80:134–146 Kumar Y, Liang C, Bo Z et al (2012) Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. PLoS Negl Trop Dis 6:e1887 Kwissa M, Nakaya HI, Onlamoon N et al (2014) Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe 16:115–127 Lech M, Avila-Ferrufino A, Skuginna V et al (2010) Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice. Int Immunol 22:717–728 Lee YR, Liu MT, Lei HY et al (2006) MCP1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 87(Pt 12):3623–3630 Libraty DH, Young PR, Pickering D et al (2002) High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 186:1165–1168 Lin C, Lei H, Liu C et al (2001) Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol 63:143–149 Lin CF, Lei HY, Shiau AL et al (2003) Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol 69:82–90 Malavige GN, Ogg GS (2017) Pathogenesis of vascular leak in dengue virus infection. Immunology 151:261–269 Martina BE, Koraka P, Osterhaus AD (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22:564–581 Martínez Gómez JM, Ong LC, Lam JH et al (2016) Maternal antibody-mediated disease enhancement in type I interferon-deficient mice leads to lethal disease associated with liver damage. PLoS Negl Trop Dis 10:e0004536 Méndez Á, González G (2006) Manifestaciones clínicas inusuales del dengue hemorrágico en niños Abnormal clinical manifestations of dengue hemorrhagic fever in children. Biomedica 26:61–70 Mikołajczyk TP, Osmenda G, Batko B et al (2016) Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus. Lupus 25:18–27 Miller JL, de Wet BJ, Martinez-Pomares L et al (2008) The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 4:e17 Modhiran N, Watterson D, Muller DA et al (2015) Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med 7:304ra142 Mongkolsapaya J, Dejnirattisai W, Xu XN et al (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9:921–927 Mukhopadhyay S, Kuhn RJ, Rossmann MG (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3:13–22 Nasirudeen AM, Wong HH, Thien P et al (2011) RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis 5:e926 Navarro-Sánchez E, Desprès P, Cedillo-Barrón L (2005) Innate immune responses to dengue virus. Arch Med Res 36:425–435 Neves-Souza PC, Azeredo EL, Zagne SM et al (2005) Inducible nitric oxide synthase (iNOS) expression in monocytes during acute dengue Fever in patients and during in vitro infection. BMC Infect Dis 5:64 Ng JK, Zhang SL, Tan HC et al (2014) First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. PLoS Pathog 10:1004031 Nguyen TH, Lei HY, Nguyen TL et al (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189:221–232 Nguyen TH, Nguyen TL, Lei HY et al (2005) Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am J Trop Med Hyg 72:370–374 Pang T, Cardosa MJ, Guzman MG (2006) Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85:43–45 Pérez AB, García G, Sierra B et al (2004) IL-10 levels in dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73:230–234 Puerta-Guardo H, Raya-Sandino A, González-Mariscal L et al (2013) The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability. J Virol 87:7486–7501 Puerta-Guardo H, Glasner DR, Harris E (2016) Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability. PLoS Pathog 12:e1005738 Qin CF, Zhao H, Liu ZY et al (2011) Retinoic acid inducible gene-I and melanoma differentiation-associated gene 5 are induced but not essential for dengue virus induced type I interferon response. Mol Biol Rep 38:3867–3873 Restrepo BN, Isaza DM, Salazar CL et al (2008) Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gama in infants with and without dengue Níveis séricos de interleucina-6, fator de necrose tumoral-alfa e interferon-gama em crianças menores de um ano com e sem dengue. Rev Soc Bras Med Trop 41:6–10 Reyes-del Valle J, Salas-Benito J, Soto-Acosta R et al (2014) Dengue virus cellular receptors and tropism. Curr Trop Med Rep 1:36–43 Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM et al (2010) Immature dengue virus: a veiled pathogen? PLoS Pathog 6:e1000718 Saha P, Geissmann F (2011) Toward a functional characterization of blood monocytes. Immunol Cell Biol 89:2–4 Saito M, Oishi K, Inoue S et al (2004) Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol 138:299–303 Schneberger D, Aharonson-Raz K, Singh B (2011) Monocyte and macrophage heterogeneity and Toll-like receptors in the lung. Cell Tissue Res 343:97–106 Simmons CP, Chau TN, Thuy TT et al (2007) Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis 196:416–424 Simmons CP, Farrar JJ, Nguyen VV et al (2012) Dengue. N Engl J Med 366:1423–1432 Skrzeczyñska J, Kobylarz K, Hartwich Z et al (2002) CD14+ CD16+ monocytes in the course of sepsis in neonates and small children: monitoring and functional studies. Scand J Immunol 55:629–638 Srikiatkhachorn A, Mathew A, Rothman AL (2017) Immune-mediated cytokine storm and its role in severe dengue. Semin Immunopathol 39:563–574 Sun P, Kochel TJ (2013) The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis. Sci World J 2013:843469 Sun P, Bauza K, Pal S et al (2011) Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement. Virology 421:245–252 Tan TY, Chu JJH (2013) Dengue virus-infected human monocytes trigger late activation of caspase-1, which mediates pro-inflammatory IL-1β secretion and pyroptosis. J Gen Virol 94(Pt 10):2215–2220 Torrentes-Carvalho A, Azeredo EL, Reis SR et al (2009) Dengue-2 infection and the induction of apoptosis in human primary monocytes. Mem Inst Oswaldo Cruz 104:1091–1099 Tsai TT, Chuang YJ, Lin YS et al (2014) Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. PLoS Negl Trop Dis 8(11):e3320 Ubol S, Phuklia W, Kalayanarooj S et al (2010) Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis 201:923–935 Urcuqui-Inchima S, Patiño C, Torres S et al (2010) Recent developments in understanding dengue virus replication. Adv Virus Res 77:1–39 Wan SW, Lin CF, Yeh TM et al (2013) Autoimmunity in dengue pathogenesis. J Formos Med Assoc 112:3–11 Weiskopf D, Angelo MA, de Azeredo EL et al (2013) Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci 110:E2046–E2053 Whitehead SS, Blaney JE, Durbin AP et al (2007) Prospects for a dengue virus vaccine. Nat Rev Microbiol 5:518–528 Whitehorn J, Yacoub S, Anders KL et al (2014) Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions. PLoS Negl Trop Dis 8:e3025 Wong KL, Tai JJ, Wong W et al (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118:e16–e31 Wong KL, Chen W, Balakrishnan T et al (2012a) Susceptibility and response of human blood monocyte subsets to primary dengue virus infection. PLoS One 7:e36435 Wong KL, Yeap WH, Tai JJ et al (2012b) The three human monocyte subsets: implications for health and disease. Immunol Res 53:41–57 World Health Organization (2009) Dengue. Guidelines for diagnosis, treatment, prevention and control. New edition 2009. WHO Press, Geneva Yoshimoto S, Nakatani K, Iwano M et al (2007) Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Am J Kidney Dis 50:47–58 Ziegler-Heitbrock HW (2000) Definition of human blood monocytes. J Leukoc Biol 67:603–606 Ziegler-Heitbrock L, Hofer TP (2013) Toward a refined definition of monocyte subsets. Front Immunol 4:23